Bifidobacterium Animalis Subsp. Lactis - Loncastuximab Tesirine-Lpyl Interaction Details

Interaction Details

There were no interactions found between Loncastuximab Tesirine-Lpyl and Bifidobacterium Animalis Subsp. Lactis. This does not mean the potential for an interaction does not exist, however. There is often a lack of studies and data surrounding traditional medicine, especially concerning drug interactions, so it is important to always consult your provider before making any changes to your medication regimen.

Still looking for more information about combining Loncastuximab Tesirine-Lpyl and Bifidobacterium Animalis Subsp. Lactis? Ask Dr. Brian Staiger about it by contacting him directly.

Loncastuximab Tesirine-Lpyl Overview

Loncastuximab tesirine-lpyl injection is used to treat a certain type of non-Hodgkin's lymphoma (NHL; a type of cancer that begins in a type of white blood cells that normally fights infection) that did not respond to or has returned after treatment with at least two other cancer treatments. Loncastuximab tesirine-lpyl is in a class of medications called antibody-drug conjugates. It works by killing cancer cells.

See More Information Regarding Loncastuximab Tesirine-lpyl Injection

Bifidobacterium Animalis Subsp. Lactis - More Interactions

Bifidobacterium Animalis Subsp. Lactis interacts with 179 drugs

Interaction Rating Key

These severity listings are for informational use only. Never start, stop or otherwise change your therapy before speaking with your provider.

Major	The combined use of these agents is strongly discouraged as serious side effects or other negative outcomes could occur.
Moderate	Use cautiously under the care of a healthcare professional or avoid this combination. A significant interaction or negative outcome could occur.
Minor	Be aware that there is a chance of an interaction. Watch for warning signs of a potential interaction.
Unknown	No interactions have been reported or no interaction data is currently available.